0001415889-24-015737.txt : 20240606
0001415889-24-015737.hdr.sgml : 20240606
20240606160622
ACCESSION NUMBER: 0001415889-24-015737
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240604
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pons Jaume
CENTRAL INDEX KEY: 0001816977
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 241025044
MAIL ADDRESS:
STREET 1: C/O ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-06062024_080618.xml
X0508
4
2024-06-04
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001816977
Pons Jaume
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
PRESIDENT & CSO
1
Common Stock
2024-06-04
4
M
0
20000
0.99
A
624205
D
Common Stock
2024-06-04
4
S
0
20000
8.4326
D
604205
D
Employee Stock Option (right to buy)
0.99
2024-06-04
4
M
0
20000
0
D
2027-03-30
Common Stock
20000
164433
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The shares subject to the option are fully vested and immediately exercisable.
/s/ Peter Garcia, by power of attorney
2024-06-06